BSE filing, NSE: CRAVATEX. Summary written from the filing by ALFA Finder's alert engine.
Cravatex Ltd: key numbers
- Share price
- ₹325.10
- Market cap
- ₹84.01 Cr
- Revenue (annual)
- ₹150.9 Cr
- Net profit (annual)
- ₹6.80 Cr
- P/E (TTM)
- 9.8×Sector 43.1×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cravatex Ltd
All →Cravatex Board Meeting Date
Cravatex Ltd intimated a Board Meeting scheduled for 03/11/2026. The agenda includes approval of unaudited Q1 and half-year financial results for the period ended 30 September 2026.
Cravatex Q1 FY27 Results: Turns Profitable, Net Profit ₹0.4 Cr
Cravatex Ltd reported revenue from operations of ₹32.2 Cr (+39.4% YoY) and net profit of ₹0.4 Cr for Q1 FY27.
- Key figure
- Net profit ₹0.4 Cr
Cravatex Board Meeting Date
Cravatex Ltd scheduled a board meeting for August 12, 2026. The meeting will consider unaudited financial results for the quarter ended June 30, 2026.
Cravatex Annual General Meeting
Cravatex Limited held its 74th Annual General Meeting on July 31, 2026. Shareholders considered financial statements, re-appointment of a director, and approved a final dividend.
Cravatex Other Announcement
Cravatex Ltd sent letters to shareholders without registered emails providing a web-link to the Annual Report 2025-26. The notice also mentions the 74th AGM.
Cravatex Annual General Meeting
Cravatex Ltd will hold its 74th AGM on 31 July 2026 via video conference. The agenda includes audited accounts and a final dividend of Rs.13 per share.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.